4.3 Article

To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction

Matthew Kahn et al.

Summary: The primary care heart failure service successfully identified and treated a missed cohort of heart failure patients with left ventricular systolic dysfunction in the community, leading to optimization of treatment and increased use of device therapy.

EUROPEAN HEART JOURNAL (2022)

Article Medicine, General & Internal

Clinical Decision Support System (CDSS) in primary care: from pragmatic use to the best approach to assess their benefit/risk profile in clinical practice

Iacopo Cricelli et al.

Summary: Clinical Decision Support Systems (CDSSs) are computer-based tools that aim to support physicians in making clinical decisions. MilleDSS is an example in Italy, covering four domains of GP-software interaction. According to the Medical Device Regulation, clinical evidence is required for any software intended for medical purposes. Therefore, it is necessary to conduct clinical research to evaluate the effectiveness of CDSS.

CURRENT MEDICAL RESEARCH AND OPINION (2022)

Article Medicine, General & Internal

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

S. D. Solomon et al.

Summary: The study shows that SGLT2 inhibitors are effective in reducing the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less. However, whether they are effective in patients with a higher left ventricular ejection fraction remains uncertain.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management

Antonio Ceriello et al.

Summary: This review highlights the relationship between type 2 diabetes and heart failure, covering the pathophysiology, diagnostic criteria, treatment drugs, and the impact on COVID-19 severity.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Medicine, General & Internal

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker et al.

Summary: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Epidemiology of heart failure

Amy Groenewegen et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

Petar M. Seferovic et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Article Primary Health Care

Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study

Clare J. Taylor et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2017)

Article Peripheral Vascular Disease

The Burden of Chronic Heart Failure in Primary Care in Italy

Carlo Piccinni et al.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2017)

Review Cardiac & Cardiovascular Systems

State of the art: Using natriuretic peptide levels in clinical practice

Alan Maisel et al.

EUROPEAN JOURNAL OF HEART FAILURE (2008)